City of Hope Medical Center
Why trials sponsored by City of Hope Medical Center stopped, in this sample of ClinicalTrials.gov.
15 stopped trials with a clear reason; 80% ended for non-scientific reasons.
| Reason | Trials | Share |
|---|---|---|
| funding business | 5 | 33% |
| slow accrual | 5 | 33% |
| logistics pi | 2 | 13% |
| other | 2 | 13% |
| futility | 1 | 7% |
Trials
- Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
NCT06575686 · SUSPENDED · other
“Pending Interim Analysis” - Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
NCT06014827 · SUSPENDED · funding business
“Budget Issue” - Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors
NCT04560439 · WITHDRAWN · funding business
“Funding” - 64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression
NCT04605614 · WITHDRAWN · slow accrual
“slow accruals” - Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation
NCT03728335 · SUSPENDED · slow accrual
“Accrual goal met” - CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma
NCT03710421 · SUSPENDED · slow accrual
“Slow/Low Accrual” - ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer
NCT03402880 · WITHDRAWN · slow accrual
“No patients enrolled” - Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis
NCT02528877 · WITHDRAWN · other
“The study design was revised so a new protocol will be opened.” - Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian Cancer
NCT01927393 · WITHDRAWN · funding business
“Study was not funded” - Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive
NCT01051544 · WITHDRAWN · logistics pi
“complete per PI” - Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer
NCT00932035 · TERMINATED · logistics pi
“Loss of principal investigator” - A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer
NCT03026803 · TERMINATED · funding business
“Due to Sorafenib became first line treatment for HCC, the designed treatment became less competitive. The company Sanofi decided not to continue to support” - Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment
NCT00538291 · TERMINATED · futility
“Study was terminated early due to lack of efficacy.” - Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma
NCT00544778 · TERMINATED · funding business
“The study was terminated prematurely due to withdrawal of support by the sponsor.” - Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer
NCT00530634 · TERMINATED · slow accrual
“Poor accrual”
Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.